Skip to main content
. 2015 Jul 21;15:78. doi: 10.1186/s12886-015-0070-7

Table 2.

Secondary endpoints: corneal thickness, maximal and minimal simulated K-readings and visual acuity in the placebo and treatment (CXL) group at the end of the trial

Placebo group CXL group
Corneal thickness (μm) at the end of follow-up 467.3 +/−24 449.2 +/−72 p = 0.96
Kmin (dpt) at the end of follow-up 46.1 +/−4.7 43.5 +/−1.7 p = 0.59
Kmax (dpt) at the end of follow-up 51.2 +/−6.9 46.9 +/−2.1 p = 0.59
Visual acuity (logMAR) at the end of follow-up 0.23 +/−0.27 0.22 +/−0.14 p = 0.61